The prevalence of signs and symptoms of childhood leukemia and lymphoma in Fars Province, Southern Iran

Cancer Detection and Prevention

Volumn 32, Issue 2, 2008, Pages 178-183

  Karimi, Mehran ^a   Mehrabani, Davood ^b   Yarmohammadi, Hooman ^a   Jahromi, Farideh Safaei ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute lymphoblastic leukemia; Acute lymphocytic leukemia; Acute myeloid leukemia; Burkitt lymphoma; Chronic myeloid leukemia; Leukemia; Lymphoma; Pediatric malignancies; Prevalence; Southern Iran

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BURKITT LYMPHOMA; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; FEMALE; FEVER; HEPATOSPLENOMEGALY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IRAN; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; UNIVERSITY HOSPITAL;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IRAN; LEUKEMIA; LYMPHOMA; MALE; PREVALENCE;

EID: 47949106305     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2008.06.001     Document Type: Article

References (39)

1. The Leukemia and Lymphoma Society. Facts 2007-2008 [Monograph on the Internet]. White Plains NY: Leukemia and Lymphoma Society, c2007 [cited 2007 Jun 27]. Available at: http://www.leukemia-lymphoma.org/attachments/National/br_1182779969.pdf.
2. Pui C.H. Acute lymphoblastic leukemia in children. Curr Opin Oncol 12 (2000) 3-12
3. Miller D.R., Coccia P.F., Bleyer W.A., Lukens J.N., Siegel S.E., Sather H.N., et al. Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Children's Cancer Study Group. J Clin Oncol 7 (1989) 1807-1815
4. Parkin DM, Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer incidence in five continents, vol. VII. Lyon: International Agency for Research on Cancer, 1997 (IARC Sci Publications No. 143).
5. Armstrong J., Pomeroy M., Fennelly J.J., and Cahalane S. Prognostic factors in childhood acute lymphoblastic leukemia. Ir J Med Sci 159 (1990) 40-43
6. Wessels G., Hesseling P.B., Buurman M., Oud C., and Nel E.D. An analysis of prognostic variables in acute lymphocytic leukemia in a heterogeneous South African population. J Trop Pediatr 43 (1997) 156-161
7. Perentesis J.P. Why is age such an important independent prognostic factor in acute lymphoblastic leukemia?. Leukemia 11 S 4 (1997) 4-7
8. Chessells J.M., Hall E., Prentice H.G., Durrant J., Bailey C.C., and Richards S.M. The impact of age on outcome in lymphoblastic leukemia, MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia 12 (1998) 463-473
9. Pollock B.H., DeBaun M.R., Camitta B.M., Shuster J.J., Ravindranath Y., Pullen D.J., et al. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a paediatric oncology group study. J Clin Oncol 18 (2000) 813-823
10. Chessells J.M., Richards S.M., Bailey C.C., Lilleyman J.S., and Eden O.B. Gender and treatment outcome in childhood lymphoblastic leukemia: report from the MRC UKALL trials. Br J Hematol 89 (1995) 364-372
11. Shuster J.J., Wacker P., Pullen J., Humbert J., Land V.J., Mahoney Jr. D.H., et al. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Paediatric Oncology Group Study. J Clin Oncol 16 (1998) 2854-2863
12. Pui C.H., Boyett J.M., Relling M.V., Harrison P.L., Rivera G.K., Behm F.G., et al. Sex differences in prognosis for children with acute lymphoblastic leukemia. J Clin Oncol 17 (1999) 818-824
13. Heerema N.A., Sather H.N., Sensel M.G., Lee M.K., Hutchinson R., Nachman J.B., et al. Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Cancer 88 (2000) 1945-1954
14. Balakirev S.A., Makhonova L.A., Tupitsyn N.N., Baryshnikov A.Iu., Artem'ev A.K., Maiakova S.A., et al. Effects of immunologic markers on prognosis in acute lymphoblastic leukemia in young children. Pediatriia 11 (1991) 37-39
15. Garand R., and Bene M.C. Incidence, clinical and laboratory features and prognostic significance of immunophenotypic subgroups in acute lymphoblastic leukemia: the GEIL experience. Recent Results Cancer Res 131 (1993) 283-295
16. Zipf T.F., Berg S.L., Roberts W.M., Poplack D.G., Steuber C.P., and Bleyer W.A. Childhood leukemias. In: Abeloff M.D., Armitage J., Lichter A.S., and Niederhuber J.E. (Eds). Clinical oncology. 2nd ed. (2000), Churchill Livingstone, New York 2402-2434
17. Hudson M.M., and Donaldson S.S. Hodgkin's disease. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 4th ed. (2002), Lippincott Williams and Wilkins, Philadelphia 637-660
18. Gilchrist G.S. Lymphoma. In: Behrman R.E., Kliegman R.M., and Jenson H.B. (Eds). Nelson textbook of pediatrics. 17th ed. (2003), Philadelphia, Saunders 1698-1702
19. Jurewicz J., and Hanke W. Exposure to pesticides and childhood risk: has there been any progress in epidemiological studies?. Int J Occup Med Environ Health 19 (2006) 152-169
20. Amr S.S., Tarawneh M.S., Jitawi S.A., and Oran L.W. Malignant neoplasms in Jordanian children. Ann Trop Paediatr 6 (1986) 61-66
21. Stirling G., Khalil A.M., Nada G.M., Saad A.A., and Raheem M.A. Malignant neoplasms in Saudi Arabia. Cancer 44 (1979) 1543-1548
22. Tabuchi K. Acute myeloid leukemia. Gan To Kagaku Ryoho 34 (2007) 156-161
23. Hill C., and Doyon F. The frequency of cancer in France: all ages and under ages 15, mortality in 2003 and trends since 1968. Bull Cancer 94 (2007) 7-13
24. Watanabe A. Recent advances in treatment of childhood acute lymphoblastc leukemia. Gan To Kagaku Ryoho 34 (2007) 150-155
25. -3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group. Przegl Lek 63 (2006) 11-14
26. Kadivar M.R., Yarmohammadi H., Mirahmadizadeh A.R., Vakili M., and Karimi M. Prevalence of iron deficiency anemia in 6 months to 5 years old children in Fars, Southern Iran. Med Sci Monit 9 2 (2003) CR100-CR104
27. Bosch X. Incidence of childhood leukemia on the increase. Lancet Oncol Middle East 3 (2005) 1
28. Yoshikawa T., Ogata N., Takahashi K., Moris S., Uemura Y., and Matsumara M. Bilateral orbital tumor as initial presenting sign in human T-cell leukemia virus-1 associated adult T-cell leukemia-lymphoma. Am J Ophthalmol 140 (2005) 327-329
29. Kaplan I., Hodak F., Ackerman L., Mimouni D., Anhalt G.J., and Calderor S. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis of non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 40 (2004) 553-562
30. Rogers L.R. Cerebrovascular complications in cancer patients. Neurol Clin 21 (2003) 167-192
31. Birch J.M., Marsden H.B., and Swindell R. Incidence of malignant disease in childhood: a 24 year review of the Manchester Children's Tumour Registry data. Br J Cancer 42 (1980) 215-223
32. Zheng T., Mayne S.T., Boyle P., Holford T.R., Liu W.L., and Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut, 1935-1988. Cancer 70 (1992) 840-849
33. Clarke C.A., and Glaser S.L. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 94 (2002) 2015-2023
34. Liu S., Semenciw R., and Mao Y. Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: age-period-cohort analysis. Hematol Oncol 21 (2003) 57-66
35. Gurney K.A., and Cartwright R.A. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematol J 3 (2002) 95-104
36. Salminen E. Age-related survival in non-Hodgkin's lymphoma. Oncology 55 (1998) 7-9
37. Hartge P., Devesa S.S., and Fraumeni Jr. J.F. Hodgkin's and non-Hodgkin's lymphomas. Cancer Surv 19 (1994) 423-453
38. Nola M., Paveletic S.Z., Weisenburger D.D., Smith L.M., Bast M.A., Vose J.M., et al. Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma. Am J Hematol 77 (2004) 31-35
39. Steurer M., Wagner H., and Gastl G. Prevalence and management of anemia in hematologic cancer patients receiving cyclic nonplatinum chemotherapy: results of a prospective national chart survey. Wien Klin Wochenschr 116 (2004) 367-372